PT-141 10 mg

THIS PRODUCT IS INTEDED AS A RESEARCH CHEMICAL ONLY.
This designation allows the use of research chemicals strictly in vitro for testing and laboratory experimentation only. All products information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professional. This product is not a drug, food or cosmetic and may not be misbranded, misused or mislabled as a drug food or cosmetic.

PT-141 10 mg (Bremelanotide) - Premium Research-Grade Melanocortin Receptor Agonist

What Is PT-141 10 mg? — A Plain Explanation

Sometimes the greatest discoveries arrive by accident. Alexander Fleming forgot to seal a Petri dish and found penicillin. A 3M chemist mixed adhesives and created the Post-it note. PT-141 shares that same unexpected story.

In the 1990s, scientists experimented with Melanotan II, hoping for a safe, UV-free tan. Their goal was simple: bronze skin without the burn. Early tests showed the peptide worked. People did darken. But they also reported something else—something no one saw coming.

The sexual arousal effects caught everyone completely off guard.

That curveball transformed everything. What scientists had accidentally discovered was this incredibly sophisticated cyclical heptapeptide from the melanocortin family—except it had an agenda nobody anticipated. Rather than simply cranking up melanin production, PT-141 was rewiring entire neural networks, targeting very specific receptors buried deep in the brain's command center.

This wasn't your typical peripheral treatment messing with blood vessels and plumbing. PT-141 bypasses all that surface-level stuff and goes directly to headquarters: the hypothalamus. It locks onto melanocortin receptors—particularly MC3R and MC4R—nestled in critical areas like the paraventricular nucleus and medial preoptic area. Think of it as a master key that opens doors other compounds can't even locate.

Twenty years of rigorous clinical development later, PT-141's pharmaceutical cousin Vyleesi earned FDA approval for treating hypoactive sexual desire disorder in premenopausal women. But for researchers? The original compound remains invaluable. It's become an essential tool for probing melanocortin receptor signaling, unraveling neuroendocrine mysteries, and understanding how peptides influence complex behavioral patterns.

PT-141 10 mg Overview — Quick Facts

What you're dealing with: A synthetic peptide that communicates directly with brain receptors

Quantity: 10 mg of pure, crystalline powder per research vial

Appearance: Fine white powder that dissolves completely in water​

Storage life: Months when properly frozen; weeks at room temperature​

Reconstitution: Bacteriostatic water works best; refrigerate after mixing​

Crucial reminder: This is exclusively for lab work—never for human consumption​

Purity standard: Over 99% pure, verified through advanced analytical testing

Chemical Makeup

PT-141: More Than Just a Peptide

PT-141 isn't ordinary. Its formula—C₅₀H₆₈N₁₄O₁₀—lands it at 1025.18 grams per mole. Yet it's not merely a chain of amino acids. It forms a precise ring: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH. That ring is no accident. It's the work of careful design, built for purpose.

The designers pulled some clever tricks here. They swapped in norleucine at position 4, which stops the molecule from breaking down through methionine oxidation. Smart move. Then they threw in D-phenylalanine instead of the usual L-form, making the whole structure much tougher against the body's digestive enzymes. The lactam bridge connecting aspartate to lysine? That's what gives PT-141 its structural backbone and keeps it stable far longer than linear peptides.

In practical terms, this stuff behaves beautifully. Mix it with sterile water or a touch of acetic acid, and it goes into solution without any drama. The pKa sits around 3.37—nothing problematic there for laboratory work. Its density of 1.43 g/cm³ means it'll sink in water, while the logP value of 3.51 indicates just enough fat-solubility to cross biological membranes when it needs to.

How PT-141 Works — Mechanism & Research

Here's where things get really interesting. PT-141 works as what scientists call a non-selective melanocortin receptor agonist, but it definitely has favorites. It shows the strongest love for MC1R, then MC4R, followed by MC3R, MC5R, and finally MC2R. But the real action—the stuff that matters—happens when it hits MC3R and MC4R deep in the hypothalamus.

The moment PT-141 locks onto its receptor, it triggers a biochemical avalanche. Adenylyl cyclase goes into overdrive, flooding the cell with cyclic adenosine monophosphate. This molecular messenger then kicks protein kinase A into action, which starts phosphorylating proteins left and right, ultimately rewiring which genes get switched on or off.

What's the end result of all this molecular chaos? Dopamine release in the medial preoptic area—a brain region that's absolutely central to sexual motivation and behavior. But PT-141 doesn't stop there. It also hits presynaptic MC4Rs on hypothalamic neurons, cranking up the release of norepinephrine and oxytocin throughout brain circuits associated with reward and arousal.

This represents a completely different approach than anything else out there. While other drugs tinker with blood vessels and plumbing, PT-141 goes straight to mission control.

The timeline is pretty impressive too. PT-141 crosses the blood-brain barrier quickly—you'll see peak plasma levels within 30 to 60 minutes. Then it keeps working for 4 to 8 hours. Researchers using c-Fos staining can actually watch this happen in real time, seeing the paraventricular nucleus light up like a pinball machine.

Research Findings & Applications

Fifteen years of clinical trials have generated some pretty compelling data. The early male studies remain fascinating. When researchers tested PT-141 against erectile dysfunction using different doses, they found clear patterns. Only 10% of guys on placebo managed normal function, but watch what happened as the doses went up: 30% at 5mg, 36% at 10mg, 53% at 15mg, and 50% at 20mg. What really caught attention was PT-141's success in men who'd already failed with Viagra and similar drugs.

The female studies told an equally compelling story. The massive RECONNECT trials—301 and 302—pulled in 1,247 premenopausal women dealing with low sexual desire. Women getting 1.75mg of bremelanotide showed measurable improvements in desire scores, with an average bump of 0.35 points compared to placebo. The statistics were rock-solid: p < 0.001.

Brain imaging studies added another fascinating layer. When researchers stuck people in MRI machines and gave them PT-141, they could see increased activity in brain regions tied to reward and sexual behavior. These changes lasted up to 24 hours and matched perfectly with what participants were reporting.

The long-term stuff proved equally reassuring. A year-long study following 684 people showed that PT-141's effects don't fade over time. Most folks settled into using it roughly once a week and kept their improvements throughout the entire study. No tolerance. No wearing off. Just consistent results.

Safety & Side Effects

Let's talk honestly about what happens when people use PT-141. Across 43 completed studies involving 3,500 subjects, researchers have built a pretty comprehensive safety database. The bottom line? Most side effects are mild to moderate and rarely force people to quit.

Nausea tops the list—40% of PT-141 users experience it, compared to just 1.3% on placebo. It's unpleasant, sure, but it usually gets better with repeated doses, and anti-nausea meds can help if needed. Flushing comes next at 20.3% versus 1.3% for placebo—that warm, red feeling that typically fades within a couple hours. Headaches hit 11.3% of users, and injection site reactions affect 5.4%.

The blood pressure thing deserves attention, though it's generally not dramatic. PT-141 causes modest increases—an average of 1.9 mmHg systolic and 1.7 mmHg diastolic. These changes peak somewhere between 2 and 8 hours after injection and usually resolve within 12 hours. Still, anyone with uncontrolled high blood pressure or heart problems should steer clear.

There's one side effect that's uncommon but concerning: skin darkening. When people take PT-141 daily—which isn't recommended—more than a third develop patches of darker skin. People with naturally darker skin seem more prone to this. The troubling part? This darkening doesn't always reverse when you stop treatment.

Throughout all these studies, nobody died from PT-141, and serious problems remained rare and generally unrelated to the drug itself. Drug interactions are limited—only naltrexone and indomethacin showed meaningful interactions.

Disclaimer: For research use only. Not for human consumption. Not FDA approved for therapeutic use. This product has not been evaluated by the Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease.